Clinical Effects of Selective Serotonin Reuptake Inhibitors
Meta-analysis of controlled clinical trials has recently been established as a discipline that critically reviews and statistically combines the results of new treatment modalities. The objectives of a meta-analysis are to increase statistical power in detecting differences between treatments and to resolve un-certainties in the case of conflicting results. A meta-analytic literature review takes the trial itself as unit of analysis and consequently gives equal weight to each trial. A study of on-file data calculates the central tendency of the pooled data set, in which the individual patient in the trial is the unit for calculation of means, standard deviations, etc.
KeywordsSelective Serotonin Reuptake Inhibitor Antidepressant Drug Hamilton Depression Scale Tricyclic Antidepres Global Improvement Scale
Unable to display preview. Download preview PDF.
- Amin M.M, Ananth J V, Coleman B S, Darcourt G, Farkes T, Goldstein B, Lapierre Y D, et al. (1984) Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study. Clin Neuropharmacol [Suppl 1] 7: 580–581Google Scholar
- Bech P (1988a) A review of the antidepressant properties of serotonin reuptake inhibitors. In: Gastpar M, Wakelin JS (eds) Selective 5-HT reuptake inhibitors: novel or commonplace agents? Karger, Basel, pp 58–69Google Scholar
- Chovinard G (1985) A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J Clin Psychiatry 46: 32–37Google Scholar
- Dick P, Ferrero E (1983) A double-blind comparative study of the clinical efficacy of fluvoxamine and clomipramine. Br J Clin Pharmacol 15: 419–425Google Scholar
- DU AG, Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology (Berlin) 90: 131–138Google Scholar
- EC, European Community (1987) Clinical investigation of antidepressant drugs. EC Brussels No 111/476/87Google Scholar
- Guelfi JD, Dreyfus JF, Pichot P, GEPECEP (1987) Fluvoxamine and imipramine: results of a long-term controlled trial. Int Clin Psyehopharmacol 2: 103–109Google Scholar
- Itil TM, Shrivastava RK, Mukherjee S, Coleman BS, Michael ST (1983) A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression. Br J Clin Pharmacol 15: 433–438Google Scholar
- Medical Research Council (1965) Clinical trial of the treatment of depressive illness. Br Med J 1: 881–886Google Scholar
- Schou M (1976) Prophylactic and maintenance therapy in recurrent affective disorders. In: Gallant DM, Simpson GM (eds) Depression: behavioral biochemical, diagnostic and treatment concept. Spectrum, New York, pp 309–326Google Scholar
- Smith A, Traganza E, Harrison G (1969) Studies of the effectiveness of antidepressant drugs. Psyehopharmacol Bull [Special issue]: 1–21Google Scholar
- Wernicke JF, Brenner JD (1986) Fluoxetine effective in the long term treatment of depression. Br J Clin Pract [Suppl 46] 40: 17–23Google Scholar